CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Smith Brandon S. Chief Operating Officer | Option exercise | +78,000 | 130,000 | ||
| 2026-07-28 | Smith Brandon S. Chief Operating Officer | Returned to the company | −78,000 | $8.56 | $668K | 52,000 |
| 2026-07-28 | Smith Brandon S. Chief Operating Officer | Option exercise · Restricted Stock Units | −78,000 | 0 | ||
| 2026-03-03 | Smith Brandon S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2025-07-28 | Smith Brandon S. Chief Operating Officer | Grant or award | +130,000 | 130,000 | ||
| 2025-03-05 | Smith Brandon S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +107,500 | 107,500 | ||
| 2024-02-27 | Smith Brandon S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,556 | $46.62 | $166K | 444 |
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −444 | $47.74 | $21K | 0 |
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 218,667 | ||
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,886 | $55.48 | $216K | 114 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −114 | $55.96 | $6K | 0 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 222,667 | ||
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −2,226 | $58.22 | $130K | 1,774 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −1,373 | $59.15 | $81K | 401 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −401 | $59.91 | $24K | 0 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 226,667 |
Page 1 of 2 · 31 trades